J
Jean-Louis Habrand
Researcher at University of Caen Lower Normandy
Publications - 138
Citations - 5635
Jean-Louis Habrand is an academic researcher from University of Caen Lower Normandy. The author has contributed to research in topics: Radiation therapy & Survival rate. The author has an hindex of 39, co-authored 138 publications receiving 5276 citations. Previous affiliations of Jean-Louis Habrand include Curie Institute & Institut Gustave Roussy.
Papers
More filters
Journal ArticleDOI
Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement.
Stéphanie Puget,Matthew R. Garnett,Alison Wray,Jacques Grill,Jean-Louis Habrand,Nathalie Bodaert,Michel Zerah,Mercia Bezerra,Dominique Renier,Alain Pierre-Kahn,Christian Sainte-Rose +10 more
TL;DR: By using a preoperative classification system to grade hypothalamic involvement and stratify treatment, the authors were able to minimize devastating morbidity in patients with craniopharyngiomas.
Journal ArticleDOI
Treatment of medulloblastoma with postoperative chemotherapy alone: an SFOP prospective trial in young children
Jacques Grill,Christian Sainte-Rose,Anne Jouvet,Jean-Claude Gentet,Odile Lejars,Didier Frappaz,François Doz,Xavier Rialland,Fabienne Pichon,Anne-Isabelle Bertozzi,Pascal Chastagner,Dominique Couanet,Jean-Louis Habrand,Marie-Anne Raquin,Marie-Cécile Le Deley,Chantal Kalifa +15 more
TL;DR: Conventional chemotherapy alone can be used to cure children with non-metastatic medulloblastoma who have gross total resection confirmed by early radiological assessment, but is not sufficient for treatment of those with metastatic or incompletely resected medullOBlastoma.
Journal ArticleDOI
Postoperative Chemotherapy Without Irradiation for Ependymoma in Children Under 5 Years of Age: A Multicenter Trial of the French Society of Pediatric Oncology
Jacques Grill,Marie-Cécile Le Deley,Danièle Gambarelli,Marie-Anne Raquin,Dominique Couanet,Alain Pierre-Kahn,Jean-Louis Habrand,François Doz,Didier Frappaz,Jean-Claude Gentet,Christine Edan,Pascal Chastagner,Chantal Kalifa +12 more
TL;DR: A significant proportion of children with ependymoma can avoid radiotherapy with prolonged adjuvant chemotherapy, and deferring irradiation at the time of relapse did not compromise overall survival of the entire patient population.
Journal ArticleDOI
Results of the Sixth International Society of Pediatric Oncology Wilms' Tumor Trial and Study: a risk-adapted therapeutic approach in Wilms' tumor.
Marie-France Tournade,C Com-Nougué,P.A. Voûte,Jean Lemerle,J de Kraker,J. F. M. Delemarre,M Burgers,Jean-Louis Habrand,Christine Moorman,D Bürger +9 more
TL;DR: Risk-adapted therapy to limit risk of sequelae is possible in stage I and stage II negative nodes patients and more intensive chemotherapy is necessary to prevent abdominal recurrences in nonirradiated stage IIN0 patients treated preoperatively.
Journal ArticleDOI
The role of radiation therapy in the management of craniopharyngioma: a 25-year experience and review of the literature
Jean-Louis Habrand,Oliver Ganry,Dominique Couanet,Vaĺerie Rouxel,Christine Levy-Piedbois,Alain Pierre-Kahn,Chantal Kalifa +6 more
TL;DR: It is remarkable that surgical salvage of local failures following RT could induce prolonged remission in 4 children, and long-term follow-up beyond 5 years is warranted in craniopharyngioma.